Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,573
Closed -$190K 379
2025
Q4
$190K Buy
+14,573
New +$177K 0.1% 581
2025
Q3
Sell
-16,317
Closed -$155K 726
2025
Q2
$155K Sell
16,317
-2,725
-14% -$29.3K 0.22% 227
2025
Q1
$231K Buy
19,042
+7,965
+72% +$114K 0.32% 153
2024
Q4
$156K Buy
+11,077
New +$175K 0.13% 342

Other funds holding JAMF

PharVision Advisers's JAMF Position: Q1 2026 in Review

PharVision Advisers sold out of Jamf (JAMF) in Q1 2026, closing a stake of 14,573 shares — an estimated $190K sold.

PharVision Advisers first reported a position in JAMF in Q4 2024 and held it in 4 quarters. The position peaked at $231K in Q1 2025. 1 fund tracked by Wall St. Rank holds JAMF as of Q1 2026.

  • PharVision Advisers reported no remaining Jamf position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,573 Jamf shares in Q1 2026, an estimated $190K.
  • PharVision Advisers first reported a position in Jamf in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Jamf position peaked at $231K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Jamf as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.